Reply to: Comment on ‘Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes’

Colaboración

Año: 2023

Schneller-Pavelescu, L; Vergara-de Caso, E; Martorell, A; Romanì, J; Lázaro, M; Vilarrasa, E; Díaz-Ley, B; Vázquez-Osorio, I; Palacios, JMS; Azaña, JM; González-López, MA; Cañueto, J; Molina-Leyva, A; Leiva-Salinas, M; Navarro-Triviño, FJ; Sánchez-Payá, J

Título: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

• D1